Contrary to what many oncologists believe, patients with metastatic breast cancer live longer on average if their chemotherapy is continued after their cancer is brought under control, a new meta-analysis shows. The new results, presented at the 35th Congress of the European Society for Medical Oncology (ESMO), address an important area of debate in cancer treatment...
More...
Linear Mode
